CBRI, Roper Hospital
Clinical research site in Charleston, South Carolina · 316 CALHOUN ST, CHARLESTON, SC 29401-1113 · (843) 724-2901
As of September 2026, 4 paid clinical trials are recruiting at CBRI, Roper Hospital in Charleston, South Carolina. Active studies at this site cover conditions such as Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma and Lung Non-Squamous Non-Small Cell Carcinoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at CBRI, Roper Hospital (4)
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Get new-trial alerts for CBRI, Roper Hospital
We'll email you whenever a new clinical trial starts recruiting at this research site in Charleston, SC. Unsubscribe anytime.
More research sites in Charleston
- Medical University of South Carolina (378 trials)
- Medical University of South Carolina (MUSC) (27 trials)
- Ralph H. Johnson VA Medical Center, Charleston, SC (22 trials)
- Ralph H Johnson VA Medical Center (11 trials)
- Medical University of South Carolina Hollings Cancer Center (7 trials)
- Ralph H. Johnson VA Health Care System (7 trials)
- MUSC (6 trials)
- MUSC Hollings Cancer Center (6 trials)
- Hollings Cancer Center (5 trials)
- GSK Investigational Site (4 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Charleston, SC · South Carolina clinical trials